CINCINNATIThe University of Cincinnati (UC) and its affiliated health care partners will receive nearly $23 million from the National Institutes of Health (NIH) to bring innovations from the laboratory bench to the bedside and to applications within the community.
The five-year funding, awarded through the NIH's institutional Clinical and Translational Science Awards (CTSA) program, will be used to support programming within UC's Center for Clinical and Translational Science and Training (CCTST). Established in 2005 as a collaborative effort among UC, Cincinnati Children's Hospital Medical Center, University Hospital and the Cincinnati Department of Veterans Affairs Medical Center, the CCTST is a research resource and "academic home" for clinical and translational scientists and programs.
UC is the first CTSA to be funded in 2009.
"Bench to bedside (translational research) is a common phrase in medicine, and turning laboratory findings into diagnostic tools or therapies for patients is the goal of academic medical centers," said David Stern, MD, College of Medicine dean and UC vice president for health affairs. "The CTSA program is a clear recognition by the NIH of the need to speed up the translation of the important work happening at the basic scientific level, and UC's award is indicative of the quality of scientific discovery happening on our campus and in the labs of our close partners."
CTSA fundingexpected to be given to only 60 institutions nationwide by 2012will eventually replace the NIH's General Clinical Research Center (GCRC) program and various other training programs.
UC's NIH-supported GCRC, housed at Cincinnati Children's Hospital Medical Center, with a satellite operation at the Cincinnati Department of Veterans Affairs Medical Center, is led by James Heubi, MD, of Cincinnati Children's and UC's department of pediatrics, and associate dean for clinical and translational research, and is credited
|Contact: Dama Kimmon|
University of Cincinnati